Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Boden

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Antimicrobial Agents and Chemotherapy|June 3, 2024
Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targetsSamuel L M Raines, Shane D Falcinelli, Jackson J Peterson, et al.
Nature Communications|December 18, 2023
Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoirMarion Pardons, Basiel Cole, Laurens Lambrechts, et al.
Plos One|June 22, 2012
Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1Marc Nischang, Roger Sutmuller, Gustavo Gers-Huber, et al.
The Journal of Infectious Diseases|March 19, 2010
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infectionMartin Markowitz, Florin Vaida, C Bradley Hare, et al.
Lancet (London, England)|March 23, 2005
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case reportMartin Markowitz, Hiroshi Mohri, Saurabh Mehandru, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2023
A truncated HIV Tat demonstrates potent and specific latency reversal activityEllen Van Gulck, Marion Pardons, Erik Nijs, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Antimicrobial Agents and Chemotherapy|June 3, 2024
Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targetsSamuel L M Raines, Shane D Falcinelli, Jackson J Peterson, et al.
Nature Communications|December 18, 2023
Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoirMarion Pardons, Basiel Cole, Laurens Lambrechts, et al.
Plos One|June 22, 2012
Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1Marc Nischang, Roger Sutmuller, Gustavo Gers-Huber, et al.
The Journal of Infectious Diseases|March 19, 2010
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infectionMartin Markowitz, Florin Vaida, C Bradley Hare, et al.
Lancet (London, England)|March 23, 2005
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case reportMartin Markowitz, Hiroshi Mohri, Saurabh Mehandru, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2023
A truncated HIV Tat demonstrates potent and specific latency reversal activityEllen Van Gulck, Marion Pardons, Erik Nijs, et al.
Pageof 3